ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

PASG Passage Bio Inc

1.27
0.05 (4.10%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 75,861
Bid Price 1.25
Ask Price 1.32
News -
Day High 1.33

Low
0.5751

52 Week Range

High
1.79

Day Low 1.22
Share Name Share Symbol Market Stock Type
Passage Bio Inc PASG NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.05 4.10% 1.27 17:37:33
Open Price Low Price High Price Close Price Previous Close
1.22 1.22 1.33 1.32 1.22
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
428 75,861 US$ 1.27 US$ 96,243 - 0.5751 - 1.79
Last Trade Type Quantity Price Currency
18:54:00 50 US$ 1.32 USD

Passage Bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
72.28M 55.60M - 0 -102.06M -1.84 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Passage Bio News

Date Time Source News Article
4/22/202406:00GlobeNewswire Inc.Passage Bio to Present at Chardan’s 8th Annual Genetic..
3/05/202406:00GlobeNewswire Inc.Passage Bio Seeks Pennsylvania College Student Candidates..
3/04/202416:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
3/04/202415:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
3/04/202406:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/04/202406:02Edgar (US Regulatory)Form 8-K - Current report
3/04/202406:00GlobeNewswire Inc.Passage Bio Reports Fourth Quarter and Full-Year 2023..
2/29/202415:06Edgar (US Regulatory)Form 8-K - Current report
2/27/202406:00GlobeNewswire Inc.Passage Bio to Participate in Upcoming Investor Conferences
2/14/202408:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202418:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/13/202418:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PASG Message Board. Create One! See More Posts on PASG Message Board See More Message Board Posts

Historical PASG Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.201.331.10061.1793,7110.075.83%
1 Month1.361.451.10061.30132,110-0.09-6.62%
3 Months0.971.790.93811.39364,4920.3030.93%
6 Months0.671.790.57511.01500,8140.6089.55%
1 Year0.991.790.57510.9652053353,3870.2828.28%
3 Years16.9419.840.57514.05331,625-15.67-92.50%
5 Years22.2738.230.57518.09316,208-21.00-94.30%

Passage Bio Description

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Your Recent History

Delayed Upgrade Clock